Skip to content

Investigating the effect of intrauterine injection of human chorionic gonadotropin (hCG) on pregnancy outcomes in the transfer of fresh embryos in cycles related to assisted reproductive technology (ART)

Investigating the effect of intrauterine injection of human chorionic gonadotropin (hCG) on pregnancy outcomes in the transfer of fresh embryos in cycles related to assisted reproductive technology (ART)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230803059016N1
Enrollment
158
Registered
2023-08-21
Start date
2023-08-27
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy. O00-O08

Interventions

Intervention 1: Intervention group: After the completion of puncture, on the day of transfer of a fresh embryo with A-B cleavage stage, injection of 500 units of hCG (volume 0.1 cc, manufactured by Ab

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 39 Years

Inclusion criteria

Inclusion criteria: Age 20 to 39 years old Embryos with A and B quality and fresh embryo transfer

Exclusion criteria

Exclusion criteria: Transfer of frozen embryo Male infertility History of myomectomy Presence of hydrosalpinx Presence of fibroids with pressure effect on endometrium and endometriosis. Age more than 40 years

Design outcomes

Primary

MeasureTime frame
Embryo implantation rate. Timepoint: Before and after the intervention. Method of measurement: Vaginal ultrasound.

Secondary

MeasureTime frame
Clinical pregnancy rate. Timepoint: Before and after the intervention. Method of measurement: Vaginal ultrasound.;Abortion rate MR. Timepoint: Before and after the intervention. Method of measurement: Vaginal ultrasound.;Ongoing pregnancy rate (OPR ). Timepoint: Before and after the intervention. Method of measurement: Vaginal ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehareh Ghahroudizadeh Abianeh

Tehran University of Medical Sciences

drghahroudi@gmail.com+98 21 8490 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026